Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis
Samantha Noteboom(Université de Bordeaux), Kerstin Ritter(Humboldt-Universität zu Berlin), Moritz Seiler(Humboldt-Universität zu Berlin), Roshan Prakash Rane(Humboldt-Universität zu Berlin), Friedemann Paul(Max Delbrück Center), Frederik Barkhof(Netherlands Institute for Neuroscience), Eva Strijbis(Amsterdam University Medical Centers), Menno M. Schoonheim(Amsterdam Neuroscience), Claudia Chien(Humboldt-Universität zu Berlin)
Cited by 13
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k